Literature DB >> 30399355

Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection.

Gary Gilmour1, Stefano Porcelli2, Valérie Bertaina-Anglade3, Estibaliz Arce4, Juergen Dukart5, Anja Hayen6, Antonio Lobo7, Raul Lopez-Anton8, Emilio Merlo Pich9, Darrel J Pemberton10, Martha N Havenith11, Jeffrey C Glennon11, Brian T Harel4, Gerard Dawson6, Hugh Marston12, Rouba Kozak4, Alessandro Serretti2.   

Abstract

Central nervous system diseases are not currently diagnosed based on knowledge of biological mechanisms underlying their symptoms. Greater understanding may be offered through an agnostic approach to traditional disease categories, where learning more about shared biological mechanisms across conditions could potentially reclassify sub-groups of patients to allow realisation of more effective treatments. This review represents the output of the collaborative group "PRISM", tasked with considering assay choices for assessment of attention and working memory in a transdiagnostic cohort of Alzheimer's disease and schizophrenia patients exhibiting symptomatic spectra of social withdrawal. A multidimensional analysis of this nature has not been previously attempted. Nominated assays (continuous performance test III, attention network test, digit symbol substitution, N-back, complex span, spatial navigation in a virtual environment) reflected a necessary compromise between the need for broad assessment of the neuropsychological constructs in question with several pragmatic criteria: patient burden, compatibility with neurophysiologic measures and availability of preclinical homologues.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer’s Disease; IMI; PRISM; schizophrenia; social withdrawal; translation; working memory

Mesh:

Year:  2018        PMID: 30399355     DOI: 10.1016/j.neubiorev.2018.09.025

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  7 in total

1.  Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment.

Authors:  Libin Xiao; Xiaowei Tang; Xiuxiu Hu; Xiaotang Feng; Ronglan Gong; Fujun Wang; Xiangrong Zhang
Journal:  Comput Intell Neurosci       Date:  2022-05-16

2.  Herpes Zoster Vaccination Reduces Risk of Dementia.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Assessment of current clinical practices for major depression in Japan using a web-based questionnaire.

Authors:  Hikaru Hori; Kentaro Yamato
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-01       Impact factor: 2.570

4.  Dual n-back working memory training evinces superior transfer effects compared to the method of loci.

Authors:  Wenjuan Li; Qiuzhu Zhang; Hongying Qiao; Donggang Jin; Ronald K Ngetich; Junjun Zhang; Zhenlan Jin; Ling Li
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

5.  In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma.

Authors:  Taoyang Yuan; Jianyou Ying; Chuzhong Li; Lu Jin; Jie Kang; Yuanyu Shi; Songbai Gui; Chunhui Liu; Rui Wang; Zhentao Zuo; Yazhuo Zhang
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

6.  Neural correlates of individual variation in two-back working memory and the relationship with fluid intelligence.

Authors:  Guangfei Li; Yu Chen; Thang M Le; Wuyi Wang; Xiaoying Tang; Chiang-Shan R Li
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

7.  Cognitive Training to Enhance Aphasia Therapy (Co-TrEAT): A Feasibility Study.

Authors:  Tijana Simic; Laura Laird; Nadia Brisson; Kathy Moretti; Jean-Luc Théorêt; Sandra E Black; Gail A Eskes; Carol Leonard; Elizabeth Rochon
Journal:  Front Rehabil Sci       Date:  2022-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.